• Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Consensus Rating of "Moderate Buy" from Analysts

    Source: Buzz FX / 05 Jan 2025 05:16:13   America/New_York


    Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat January 5, 2025 Share Link copied to clipboard. Shares of Alnylam Pharmaceuticals, Inc.
    Read more...
Share on,